The Cooper Companies, Inc.
COO
Positions held
Your positionsCOO isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-07.
- The Cooper Companies operates in a growing healthcare sector, focusing on innovative medical instruments and supplies, which positions it well against competitors.
- The company's revenue for 2026-Q3 was $1.066 billion, showing a strong operating margin of 20.8%.
- Earnings growth for the last year was 3.57%, indicating a positive trend in profitability.
- The company's recent quarterly performance shows volatility, with a significant drop in operating margin to -2.87% in 2026-Q2.
- In 2026-Q2, net income was reported at -$77.9 million, highlighting potential financial instability.
- The stock has a sell signal with a score of -12.00, indicating bearish market sentiment.
Fundamentals
| Market cap | $10.33B | Enterprise value | $12.97B | Trailing P/E | 18.66 | Forward P/E | 11.57 |
| PEG | 0.51 | Price / book | 1.24 | Beta | 0.83 | Dividend yield | 0.00% |
| Revenue growth | 0.6% | Earnings growth | 357.1% | Gross margin | 65.9% | Operating margin | 20.8% |
| Profit margin | 13.5% | ROE | 6.8% | ROA | 2.7% | Debt / equity | 0.34 |
| Current ratio | 1.22 | Free cash flow | $542.65M | Analyst recommendation | hold | Mean target | $65.80 |
| 52w high | $89.83 | 52w low | $51.01 |
Quarterly
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | |
|---|---|---|---|---|---|
| Revenue | $1.1B | $1.1B | $1.0B | $1.1B | $1.1B |
| Op margin | 20.8% | -2.9% | 20.8% | 13.2% | 16.6% |
| Net income | $433M | -$77.9M | $131M | $84.6M | $98.3M |
| Gross margin | 66.8% | 68.0% | 67.9% | 61.1% | 65.3% |
| Gross profit | $712M | $735M | $695M | $651M | $692M |
| Operating income | $222M | -$31.0M | $213M | $140M | $176M |
- Revenue -1% vs prior quarter ($1.1B vs $1.1B).
- Gross margin 66.8% (was 68% prior quarter).
- Operating margin expanded to 20.8%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $4.1B | $3.9B | $3.6B | $3.3B | — |
| Op margin | 16.7% | 18.1% | 14.8% | 15.3% | — |
| Net income | $375M | $392M | $294M | $386M | — |
| Gross margin | 65.5% | 66.6% | 65.6% | 64.7% | — |
| Gross profit | $2.7B | $2.6B | $2.4B | $2.1B | — |
| Operating income | $683M | $706M | $533M | $508M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-09 · Why Is The Cooper Companies (COO) Up 0.2% Since Last Earnings Report?
2026-10-07 · Cooper Companies Director Kurzius Buys 10,000 Shares for $539,100. What Does This Insider See in Shares?
2026-10-07 · Recently Appointed Cooper Companies Director Paul Keel Buys $250,000 Stock. Does This Signal Shares are a Buy?
2026-10-07 · Flutter upgraded, AppFolio downgraded: Wall Street's top analyst calls
2026-10-02 · Cooper Companies Director Kurzius Buys $549,300 in Shares. Is the Eye Care Stock About to Rally?
2026-09-28 · Is Jana Partners Right that Cooper (COO) Needs a Different Kind of Leadership?
2026-09-26 · Is Cooper Companies (COO) Undervalued After Opening Its New Vision Centre?
2026-09-24 · COO Unveils New Innovation Hub & Lens Launch Plans to Aid CooperVision
2026-09-24 · CooperCompanies (COO) Keeps CooperSurgical and Expands Buybacks. What Did the Strategic Review Reveal?
Price (daily)
Full chart · RSI · MACD · patterns